skip to page content
Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Systems Research

Go to the VA ORD website
Go to the QUERI website

CDA 19-234 – HSR Study

 
CDA 19-234
Developing Comprehensive Screening and Treatment for Intimate Partner Violence Perpetration
Galina Portnoy, PhD
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, CT
Funding Period: October 2020 - September 2025

Abstract

Background: Intimate partner violence (IPV) is a major public health concern with significant negative consequences for those who experience it and wide-ranging impact on children, families, and the healthcare system. However, IPV is an especially prevalent health issue for Veterans, who are at increased risk of both experiencing and perpetrating IPV. More than one out of three women Veterans experience IPV and up to 60% of Veteran men report IPV perpetration. Although VHA currently recommends routine screening of IPV experiences among women Veterans, no guidelines or instruments currently exist for IPV perpetration screening. Moreover, effective intervention development for IPV perpetration is in its infancy with no evidence- based individual treatment available for IPV perpetration. In order to improve Veterans' health and reduce rates of IPV, effective and acceptable screening and treatment for IPV perpetration must exist. Significance/Impact: IPV perpetration detection, followed by behavioral intervention, are urgently needed for IPV cessation and improved health of Veterans with these common presenting problems. Yet there has been little progress to develop tools and procedures for IPV perpetration, and no guidelines on best practices for IPV perpetration screening or treatment exist. The findings of the proposed research will improve the health and functioning of Veterans and their families, enhance much needed healthcare response for this population, and inform VHA national efforts for IPV response among Veterans. Innovation: This project is innovative in its focus on IPV perpetration. With the majority of IPV research focusing on IPV victimization, there is currently a significant gap in knowledge related to IPV perpetration, including limited tools and procedures with which to address perpetration of IPV among Veterans. Enhancing services for those who experience IPV is essential, but insufficient. In order to reduce and prevent IPV, a comprehensive healthcare response necessitates implementing validated screening to detect IPV perpetration among Veterans and developing intervention protocols to address IPV perpetration. Completion of the CDA research aims will provide VHA with the data and tools necessary to inform IPV efforts, practices, and policy. Aims: The primary objective of this research is to decrease IPV among Veterans. To do so, we must have effective and acceptable tools and protocols. Aim 1: Evaluate the psychometric properties and cut-scores of a previously developed IPV screening tool. Aim 2: Identify an effective IPV perpetration intervention process and essential treatment components and develop an intervention manual. Aim 3: Conduct a pilot study of the IPV perpetration manualized intervention in a sample of Veterans. Methodology: For Aim 1, we will calculate the sensitivity, specificity, positive and negative predictive value, and positive and negative likelihood ratios of the screening instrument in comparison to the reference standard in a sample of [male] Veterans (n=113). To achieve Aim 2, we will a) engage in a consensus process with IPV experts to select intervention components from four pre-existing treatment models; b) solicit Veterans’ feedback through focus group discussions (n=4 focus groups); and c) refine the intervention, develop intervention manual, and present manual to stakeholders. For Aim 3, we will use a pre-post design to assess feasibility, safety, acceptability, and satisfaction (primary outcomes) and patient- and partner-reported changes on indicators of psychosocial health (secondary outcomes) among Veterans (n=20). Next Steps/Implementation: Research proposed in this CDA will provide the necessary groundwork for developing and implementing screening and intervention for IPV perpetration among Veterans, a critical need in VA care. Completion of these aims will inform an IIR proposal, to further evaluate and implement VHA's IPV perpetration response. Specifically, I will use findings from the CDA to refine the manualized IPV perpetration intervention, which I will then test in a larger Hybrid Type 1 effectiveness-implementation trial.

External Links for this Project

NIH Reporter

Grant Number: IK2HX002897-01A1
Link: https://reporter.nih.gov/project-details/9949045



Dimensions for VA

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

Learn more about Dimensions for VA.

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.
    Search Dimensions for this project

PUBLICATIONS:


Journal Articles

  1. Portnoy GA, Iverson KM, Haskell SG, Czarnogorski M, Gerber MR. A Multisite Quality Improvement Initiative to Enhance the Adoption of Screening Practices for Intimate Partner Violence Into Routine Primary Care for Women Veterans. Public health reports (Washington, D.C. : 1974). 2021 Jan 1; 136(1):52-60. [view]
  2. Portnoy GA, Doran JM, Isom JE, Wilkins KM, DeViva JC, Stacy MA. An evidence-based path forward for diversity training in medicine. The lancet. Psychiatry. 2021 Mar 1; 8(3):181-182. [view]
  3. Iverson KM, Dardis CM, Cowlishaw S, Webermann AR, Shayani DR, Dichter ME, Mitchell KS, Mattocks KM, Gerber MR, Portnoy GR. Effects of Intimate Partner Violence During COVID-19 and Pandemic-Related Stress on the Mental and Physical Health of Women Veterans. Journal of general internal medicine. 2022 Sep 1; 37(Suppl 3):724-733. [view]
  4. Iverson KM, Stolzmann KL, Brady JE, Adjognon OL, Dichter ME, Lew RA, Gerber MR, Portnoy GA, Iqbal S, Haskell SG, Bruce LE, Miller CJ. Integrating Intimate Partner Violence Screening Programs in Primary Care: Results from a Hybrid-II Implementation-Effectiveness RCT. American journal of preventive medicine. 2023 Aug 1; 65(2):251-260. [view]
  5. Warren AR, Relyea MR, Gross GM, Eleazer JR, Goulet JL, Brandt CA, Haskell SG, Portnoy GA. Intimate partner violence among lesbian, gay, and bisexual veterans. Psychological Services. 2023 Aug 21. [view]
  6. Portnoy G, Bruce LE, Buckholdt KE. Intimate Partner Violence Programs for Veterans: Future Directions for Research and Clinical Practice. Journal of aggression, maltreatment & trauma. 2023 May 24; 32(7-8):1170-1179. [view]
  7. Portnoy G, Buckholdt KE, Bruce LE. Introduction to the Special Issue on the Systematic Response to Intimate Partner Violence and Programs for Veterans. Journal of aggression, maltreatment & trauma. 2023 May 11; 32(7-8):951-959. [view]
  8. Adams LJ, MacLean RR, Portnoy GA, Beauvais J, Stacy MA. Psychology trainee and supervisor perspectives of multicultural supervision. Psychological Services. 2022 Mar 21. [view]
  9. Portnoy GA, Relyea MR, Presseau C, Orazietti SA, Bruce LE, Brandt CA, Martino S. Screening for Intimate Partner Violence Experience and Use in the Veterans Health Administration. JAMA Network Open. 2023 Oct 2; 6(10):e2337685. [view]
  10. Adjognon OL, Brady JE, Iverson KM, Stolzmann K, Dichter ME, Lew RA, Gerber MR, Portnoy GA, Iqbal S, Haskell SG, Bruce LAE, Miller CJ. Using the Matrixed Multiple Case Study approach to identify factors affecting the uptake of IPV screening programs following the use of implementation facilitation. Implementation science communications. 2023 Nov 21; 4(1):145. [view]


DRA: Health Systems, Mental, Cognitive and Behavioral Disorders
DRE: TRL - Development, Technology Development and Assessment
Keywords: Career Development, Intimate Partner Violence, Risk Factors
MeSH Terms: None at this time.

Questions about the HSR website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.